Form D · Biotechnology
Apollomics Inc.
Foster City, CA · CIK 0001944885
Offering snapshot reported Aug 19, 2026 · SEC filing
- Reported sold
- $10M Offering amount: $10M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Aug 14, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 19, 2026 | Initial | $10,000,000 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-594675
Class A Common Shares
Source: Form D, filed Aug 19, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Hong Jung (Moses) Chen | Director |
| Yi Kuei (Alex) Chen | Director, Executive |
| Hung Wen (Howard) Chen | Director, Executive |
| Ya Chi (Claudia) Huang | Director |
| Peter Lin | Executive |
| Hsien Shu (Jerry) Tsai | Director |
| Hung Hsien Yen | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
989 Hillsdale Blvd. Suite 220
Foster City, CA, 94404
Phone: 650-209-4055
Foster City, CA, 94404
Phone: 650-209-4055